Compare ATRA & PHUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATRA | PHUN |
|---|---|---|
| Founded | 2012 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.9M | 39.3M |
| IPO Year | 2014 | 2016 |
| Metric | ATRA | PHUN |
|---|---|---|
| Price | $8.45 | $2.13 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 2 | 2 |
| Target Price | $5.00 | ★ $7.25 |
| AVG Volume (30 Days) | 59.0K | ★ 94.1K |
| Earning Date | 05-13-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 122.52 | 39.36 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $120,772,000.00 | $30,883,000.00 |
| Revenue This Year | N/A | $89.86 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 15.57 |
| 52 Week Low | $3.92 | $1.56 |
| 52 Week High | $19.15 | $3.13 |
| Indicator | ATRA | PHUN |
|---|---|---|
| Relative Strength Index (RSI) | 43.46 | 55.26 |
| Support Level | $7.65 | $1.79 |
| Resistance Level | $11.17 | $2.28 |
| Average True Range (ATR) | 0.59 | 0.08 |
| MACD | 0.07 | 0.00 |
| Stochastic Oscillator | 50.00 | 68.42 |
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).
Phunware Inc is a software company. It is a cloud platform for mobile that provides companies with the products, solutions, and data and services necessary to engage, manage and monetize its mobile application audiences. It derives maximum revenue from United States. The company has two reportable segments: Software subscriptions and services; and Advertising. It derives maximum revenue from Software subscriptions and services. Development services for customers who wish to have a customized application experience; and In-app advertising services for mobile audience building, user acquisition, application discovery, audience engagement and monetization.